A detailed history of Al Ti Global, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Al Ti Global, Inc. holds 4,000 shares of CRL stock, worth $744,400. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,005 0.12%
Holding current value
$744,400
Previous $827 Million 4.77%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $939 - $1,226
-5 Reduced 0.12%
4,000 $788 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $73,681 - $95,936
-357 Reduced 8.18%
4,005 $827 Million
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $814 - $1,093
4 Added 0.09%
4,362 $1.18 Billion
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $716,978 - $1.04 Million
4,358 New
4,358 $1.03 Billion

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.